Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.

Effect of PAR2 in regulating TNF-α and NAD(P)H oxidase in coronary arterioles in type 2 diabetic mice.
复制标题

DOI:
10.1007/s00395-010-0129-9
复制
发表时间:
2011-01
影响因子:
9.5
通讯作者:
Zhang C
Zhang C
中科院分区:
医学1区
文献类型:
--
作者:
Park Y;Yang J;Zhang H;Chen X;Zhang C

文献摘要

参考文献

被引文献

相似文献

蛋白酶活化受体-2 (PAR2)在内皮细胞中表达并介导内皮依赖性血管舒张。我们假设PAR2调节肿瘤坏死因子-α (TNF-α)诱导的2型糖尿病(db/db)小鼠冠状动脉功能障碍。为了验证这一点,将WT对照组、db/db、经PAR2拮抗剂FSLLRY-NH2 (db/db+ FSLLRY-NH2)处理的db/db小鼠和TNF (dbTNF - /dbTNF -)无效的db/db小鼠的冠状动脉分离并加压(60 cmH2O),无血流。尽管在WT、db/db、db/db+ fslly - nh2和dbTNF - /dbTNF -中,内皮依赖性乙酰胆碱(ACh)-和血流介导的血管舒张作用在db/db小鼠中受损,但在dbTNF - /dbTNF -小鼠和PAR2拮抗剂处理的db/db小鼠中增强。NOS抑制剂ng -硝基-l-精氨酸甲酯(l-NAME)可显著降低乙酰胆碱诱导的WT、dbTNF - /dbTNF -和db/db+ FSLLRY-NH2的舒张,但不改变db/db小鼠的血管舒张。相比之下,环氧化酶(COX)抑制剂吲哚美辛(indomethacin, Indo)在这四组小鼠中没有改变疼痛诱导的血管舒张。PAR2激活肽(PAR2- ap, 2-Furoyl-LIGRLO-am)诱导的扩张性在db/db小鼠中高于WT、dbTNF - /dbTNF -和db/db小鼠。这些影响通过剥蚀或l-NAME或Indo的存在而消除。与WT小鼠相比,db/db小鼠心脏和离体冠状动脉中TNF-α、PAR2、gp91phox和p47phox的蛋白表达更高。给db/db小鼠PAR2拮抗剂可降低TNF-α、gp91phox和PAR2的蛋白表达。与db/db小鼠相比,dbTNF - /dbTNF -中gp91phox和p47phox的蛋白表达较低。这些结果表明,PAR2通过上调TNF-α的表达/产生和激活NAD(P)H氧化酶亚基p47phox,在2型糖尿病内皮功能障碍中起关键作用。
Protease-activated receptor-2 (PAR2) is expressed in endothelial cells and mediates endothelium-dependent vasodilation. We hypothesized that PAR2 regulates tumor necrosis factor-alpha (TNF-α)-induced coronary arteriolar dysfunction in type 2 diabetic (db/db) mice. To test this, coronary arterioles from WT control, db/db, db/db mice treated with PAR2 antagonist FSLLRY–NH2 (db/db+FSLLRY–NH2) and db/db mice null for TNF (dbTNF–/dbTNF–) were isolated and pressurized (60 cmH2O) without flow. Although vasodilation to the endothelium-independent vasodilator sodium nitroprusside (SNP) was not different among WT, db/db, db/db+FSLLRY–NH2 and dbTNF–/dbTNF–, endothelium-dependent acetylcholine (ACh)- and flow-mediated vasodilation were impaired in db/db mice but were enhanced in dbTNF–/dbTNF– mice and db/db mice treated with PAR2 antagonist. NOS inhibitor NG-nitro-l-arginine-methyl ester (l-NAME) significantly reduced ACh-induced dilation in WT, dbTNF–/dbTNF– and db/db+FSLLRY–NH2, but did not alter the vasodilation in db/db mice. In contrast, cyclooxygenase (COX) inhibitor indomethacin (Indo) did not alter ACh-induced vasodilation in these four groups of mice. PAR2-activating peptide (PAR2-AP, 2-Furoyl-LIGRLO-am)-induced dilation was higher in db/db mice than that in WT, dbTNF–/dbTNF– and db/db mice treated with PAR2 antagonist. These effects were abolished by denudation, or in the presence of l-NAME or Indo. Protein expressions of TNF-α, PAR2, gp91phox and p47phox in the heart and isolated coronary arterioles were higher in db/db mice compared to WT mice. Administration of PAR2 antagonist to db/db mice reduced protein expression of TNF-α, gp91phox and PAR2. Protein expression of gp91phox and p47phox was lower in dbTNF–/dbTNF– compared to db/db mice. These results indicate that PAR2 plays a pivotal role in endothelial dysfunction in type 2 diabetes by up-regulating the expression/production of TNF-α and activating NAD(P)H oxidase subunit p47phox.
DOI: 10.2337/diabetes.52.7.1799
发表时间: 2003-07-01
期刊: DIABETES
影响因子: 7.7
作者:
Duncan, BB;Schmidt, MI;Heiss, G
通讯作者: Heiss, G
DOI: 10.1074/jbc.271.25.14910
发表时间: 1996-06-21
影响因子: 4.8
作者:
Nystedt, S;Ramakrishnan, V;Sundelin, J
通讯作者: Sundelin, J
DOI: 10.2353/ajpath.2006.060042
发表时间: 2006-08-01
影响因子: 6
作者:
Ebrahimian, Teni G.;Heymes, Christophe;Silvestre, Jean-Sebastien
通讯作者: Silvestre, Jean-Sebastien
DOI: 10.1152/ajplung.00286.2003
发表时间: 2004-02-01
影响因子: 4.9
作者:
Lan, RS;Stewart, GA;Henry, PJ
通讯作者: Henry, PJ